Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish He... von Hitt, R., Iglesias, L., López-Pousa, A., Berrocal-Jaime, A., Grau, J. J., García-Girón, C., Martínez-Trufero, J., Guix, M., Lambea-Sorrosal, J., del Barco-Morillo, E., León-Vintró, X., Cunquero-Tomas, A. J., Baste, N., Ocaña, A., Cruz-Hernández, J. J.

Volltext

Cutaneous sarcoidosis in a melanoma patient under Ipilimumab therapy von Martínez Leboráns, L., Esteve Martínez, A., Victoria Martínez, A. M., Alegre de Miquel, V., Berrocal Jaime, A.

Volltext

Phase II multicenter, single arm, open label study of nivolumab in combination with ipilimumab in untreated patients with metastatic uveal melanoma (GEM1402.NCT02626962) von Piulats Rodriguez, J.M., De La Cruz Merino, L., Espinosa, E., Alonso Carrión, L., Martin Algarra, S., López-Castro, R., Curiel García, M.T., Rodriguez Abreu, D., Rullan Iriarte, A.J., Berrocal Jaime, A.

Volltext

Safety and efficacy of nivolumab (nivo) in platinum-refractory recurrent/metastastic head and neck squamous cell (PR R/M HNSCC) patients (pts): Real-life experience von Bruixola, G., Caballero Daroqui, J., Cunquero Tomas, A.J., Sandiego, S., García Sánchez, J., Blasco, S., Ochenduszko, S., Iranzo, A., Lavernia, J., Berrocal Jaime, A., Pastor Borgoñón, M.

Volltext

Determination of DPYD polymorphisms before treatment with chemotherapy with a pyrimidine: Should we continue doing it? von Avila Andrade, C, Cunquero Tomas, A J, Fernandez Diaz, A B, Meri Abad, M, Condori Farfan, L D, Shaheen, I, Cervantes Garcia, S, Safont Aguilera, M J, Iranzo Gonzalez-Cruz, V, Sforza, V, Caballero, C, Godes de Bremond, M C, Gil, M, Aparisi Aparisi, F D A, Blasco Cordellat, A, Berrocal Jaime, A, Ferrer Bolufer, I, Lobo de Mena, M, Marcaida Benito, G, Camps, C

Volltext

1080MO Sitravatinib plus tislelizumab for metastatic uveal melanoma with liver metastasis: The open-label, multicenter, phase II GEM-2101 trial von de Carpio Huerta, L.P., Espinosa, E., Cruz Merino, L. de la, Berrocal-Jaime, A., Piulats, J.M.

Volltext

1075PSafety and efficacy of nivolumab (nivo) in platinum-refractory recurrent/metastastic head and neck squamous cell (PR R/M HNSCC) patients (pts): Real-life experience von Bruixola, G, Caballero Daroqui, J, Cunquero Tomas, A J, Sandiego, S, García Sánchez, J, Blasco, S, Ochenduszko, S, Iranzo, A, Lavernia, J, Berrocal Jaime, A, Pastor Borgoñón, M

Volltext

1247PDPhase II multicenter, single arm, open label study of nivolumab in combination with ipilimumab in untreated patients with metastatic uveal melanoma (GEM1402.NCT02626962) von Piulats Rodriguez, J M, De La Cruz Merino, L, Espinosa, E, Alonso Carrión, L, Martin Algarra, S, López-Castro, R, Curiel García, M T, Rodriguez Abreu, D, Rullan Iriarte, A J, Berrocal Jaime, A

Volltext

562PDetermination of DPYD polymorphisms before treatment with chemotherapy with a pyrimidine: Should we continue doing it? von Avila Andrade, C, Cunquero Tomas, A J, Fernandez Diaz, A B, Meri Abad, M, Condori Farfan, L D, Shaheen, I, Cervantes Garcia, S, Safont Aguilera, M J, Iranzo Gonzalez-Cruz, V, Sforza, V, Caballero, C, Godes de Bremond, M C, Gil, M, Aparisi Aparisi, F D A, Blasco Cordellat, A, Berrocal Jaime, A, Ferrer Bolufer, I, Lobo de Mena, M, Marcaida Benito, G, Camps, C

Volltext

Cutaneous sarcoidosis in a melanoma patient under Ipilimumab therapy von Martínez Leboráns, L., Esteve Martínez, A., Victoria Martínez, A. M., Alegre de Miquel, V., Berrocal Jaime, A.

Volltext

Cutaneous sarcoidosis in a melanoma patient under Ipilimumab therapy: Sarcoidosis induced by Ipilimumab therapy von Martínez Leboráns, L., Esteve Martínez, A., Victoria Martínez, A. M., Alegre de Miquel, V., Berrocal Jaime, A.

Volltext

Second-line treatment with gemcitabine and vinorelbine in non-small-cell lung cancer (NSCLC) cisplatin failures: a pilot study von Herrero, Carlos Camps, Noguerón Martı́nez, Esther, Jaime, Alfonso Berrocal

Volltext

Corrigendum to “Second line treatment with gemcitabine and vinorelbine in non-small-cell lung cancer (NSCLC) cisplatin failures: a pilot study”: [Lung Cancer 27 (2000) 47–53] von Camps, Carlos, Noguerón Martı́nez, Esther, Berrocal Jaime, Alfonso

Volltext

Cutaneous sarcoidosis in a melanoma patient under Ipilimumab therapy von Martínez Leboráns, L, Esteve Martínez, A, Victoria Martínez, A M, Alegre de Miquel, V, Berrocal Jaime, A

Volltext

A Novel Routing Scheme for Creating Opportunistic Context-Virtual Networks in IoT Scenarios von Galán-Jiménez, Jaime, Berrocal, Javier, Garcia-Alonso, Jose, Azabal, Manuel Jesús

Volltext

Flow-based Service Time optimization in software-defined networks using Deep Reinforcement Learning von Jiménez-Lázaro, Manuel, Berrocal, Javier, Galán-Jiménez, Jaime

Volltext

A self-sustainable opportunistic solution for emergency detection in ageing people living in rural areas von Jesús-Azabal, Manuel, Berrocal, Javier, Soares, Vasco N. G. J., García-Alonso, José, Galán-Jiménez, Jaime

Volltext

Energy-efficient and solar powered mission planning of UAV swarms to reduce the coverage gap in rural areas: The 3D case von Galán-Jiménez, Jaime, Moguel, Enrique, García-Alonso, José, Berrocal, Javier

Volltext

Nivolumab Plus Ipilimumab for Treatment-Naive Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402) von Maria Piulats, Jose, Espinosa, Enrique, de la Cruz-Merino, Luis, Varela, Mar, Alonso Carrion, Lorenzo, Martin-Algarra, Salvador, Lopez Castro, Rafael, Curiel, Teresa, Rodriguez-Abreu, Delvys, Redrado, Miriam, Goma, Montserrat, Jose Rullan, Antonio, Calvo Gonzalez, Alfonso, Berrocal-Jaime, Alfonso

Volltext

Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trial von González Cao, María, Montagut Viladot, Clara, Berrocal Jaime, Alfonso

Volltext